Search Results - drew+weissman

1 Results Sort By:
Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for Hepatitic C
Value Proposition·      Compositions for inducing anti-HCV immune responses ·      Nucleoside-modified RNA encoding one or more HCV antigens to induce robust preventive or therapeutic adaptive immune responses against HCV   Unmet Need·      Hepatitis C virus (HCV) infection remains a significant clinical burden and is the leading cause of liver transplantation...
Published: 10/4/2024   |   Inventor(s): Justin Bailey, Stuart Ray, James Crowe, Andrew Flyak, George Shaw, Drew Weissman
Keywords(s):  
Category(s): Technology Classifications > Diagnostics
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum